Published: 2019-11-25

Evaluation of factors influencing hypertension among adults of South Karnataka - India

Darshan Kumar H. S., Karthik N. Sasalu, Suresh S. R.


Background: Studies have shown that BP is an independent risk factor for CVD. This relationship is independent as well as consistent and continuous. Observations involving more than 1 million individuals have shown that death from both CVD and stroke increases progressively and linearly from BP levels of as low as 115mm systolic and 75 mm diastolic upwards. The increased risks are present in all age groups ranging from 40 to 89 years old. Hence the present study was undertaken to evaluate the factors influencing hypertension among Adults.

Methods: In the present study 400 patients both out-patient and in-patients attending Adichuchanagiri Institute of Medical Sciences were evaluated for factors influencing Hypertension and other cardiovascular diseases. The 400 patients were divided into 200 cases who were again divided into categories based on severity of hypertension into stage 1 and stage 2 and duration of <5 years and ≥5 years.

Results: A positive correlation was found between the severity of hypertension, the patients who were found to be having stage 2 hypertension had an increase in SUA levels which was statistically significant when compared with those with stage 1 hypertension. 

Conclusions: With the results based on the study carried out author concluded that there is direct relation between hyperuricemia and hypertension. Also, the study showed that the SUA levels were significantly increased in patients with Stage 2 hypertension as compared with those of stage 1 hypertension, showing that the severity of hypertension also related to the SUA levels.


Blood pressure, Cardiovascular diseases, Hypertension, Hyperuricemia, Serum uric acid

Full Text:



Lewington S, Clerk R, Qizilbash N. A meta-analysis of individual data for 1 million adults in 61 prospective studies. Prospective Studies Collaboration. Lancet. 2002;360:1903-13.

SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265(24):3255-64.

Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, De Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999;282(6):539-46.

Kaplan NM. Braunwald’s textbook of Cardiovascular Medicine 7th Ed. Systemic Hypertension: Mechanism and Diagnosis. Elsevier Saunders. 2007;37:962.

Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. The Lancet. 2001;358(9294):1682-6.

Naomi DL Fischer, Gordon H. Williams. Hypertensive Vascular Diseases”, Harrison’s Textbook of Internal Medicine 16th ed, 2;1463-65.

Luft FC. Hypertension as a complex genetic trait. In Seminars in nephrol. 2002; 22:115-26.

Collaboration PS. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-13.

Tykarski A. Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron. 1991;59(3):364-8.

Kaplan NM. Systemic Hypertension: Mechanisms and Diagnosis. in Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, eds. Braunwald E, ed. Philadelphia: Saunders; 2005.

Fessel WJ. Renal outcomes of gout and hyperuricemia. The Am J med. 1979;67(1):74-82.

Ramsay LE. Hyperuricaemia in hypertension: role of alcohol. Br Med J. 1979;1(6164):653-4.

Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH. Hyperuricemia in primary and renal hypertension. New Engl J Med. 1966;275(9):457-64.

Puig JG, Ruilope LM. Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens. 1999;17(7):869-72.

McCord JM. Oxygen-derived free radicals in postischemic tissue injury. New Engl J Med.1985;312(3):159-63.

Lacy F, O’Connor DT, Schmid-Schoenbein GW. Elevation in plasma hydrogen peroxide in hypertensive and normotensive subjects at genetic risk for hypertension. J Hypertens.1998;16:292-303.